BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2872037)

  • 21. [L-asparaginase in the treatment of acute leukoses].
    Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
    Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 23. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME; Ertel I; Hammond GD
    Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.
    Yoshimoto T; Nishimura H; Saito Y; Sakurai K; Kamisaki Y; Wada H; Sako M; Tsujino G; Inada Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1264-70. PubMed ID: 3102431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-asparaginase in treatment of acute leukemia in children.
    Misíková Z; Cáp J
    Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-asparaginase activity in plasma and other biological fluids.
    Schwartz MK; Lash ED; Oettgen HF; Tomato FA
    Cancer; 1970 Feb; 25(2):244-52. PubMed ID: 4905152
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enzyme therapy of hemoblastosis with L-asparaginase].
    Pietschmann H; Kolarz G
    Wien Z Inn Med; 1969; 50(4):148-56. PubMed ID: 5262208
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli L-asparaginase.
    Soares AL; Guimarães GM; Polakiewicz B; de Moraes Pitombo RN; Abrahão-Neto J
    Int J Pharm; 2002 Apr; 237(1-2):163-70. PubMed ID: 11955814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures.
    Dellinger CT; Miale TD
    Cancer; 1976 Oct; 38(4):1843-6. PubMed ID: 791476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

  • 36. PEG-linked asparaginase marketed.
    Am J Hosp Pharm; 1994 Jun; 51(11):1382. PubMed ID: 7942872
    [No Abstract]   [Full Text] [Related]  

  • 37. A preliminary study on the evaluation of asparaginase. Polyethylene glycol conjugate against canine malignant lymphoma.
    MacEwen EG; Rosenthal R; Matus R; Viau AT; Abuchowski A
    Cancer; 1987 Jun; 59(12):2011-5. PubMed ID: 3567863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [L-asparaginase in the treatment of the acute leukemias. Biological aspects].
    Astaldi G
    Sangre (Barc); 1971; 16(1):1-6. PubMed ID: 5280755
    [No Abstract]   [Full Text] [Related]  

  • 39. [L-asparaginase in the treatment of leukemia].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtini E; Bruschelli M; Astaldi A
    Przegl Lek; 1971; 27(3):286-9. PubMed ID: 5280473
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of L-asparaginase therapy upon serum pseudocholinesterase and ceruloplasmin levels in patients with acute leukemia.
    Cucuianu M; Bornuz F; Macavei I
    Clin Chim Acta; 1972 Apr; 38(1):97-102. PubMed ID: 4503714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.